Article Type
Commentary
Published
The authors provide their view about the possible factors triggering clinical complexity, the key issues of clinical complexity and the related unmet needs in breast cancer.
Commentary
The authors provide their view about the possible factors triggering clinical complexity, the key issues of clinical complexity and the related unmet needs in breast cancer.
Review
Review
This article evaluates existing literature through such means as drug databases and package inserts along with PubMed/Medline, Embase, and Google Scholar databases to develop a reference tool for providers to utilize when there is a decision to treat a patient with ART and oral oncolytic agents concurrently.
Original Research
This article examines the relationship between U.S. Food and Drug Administration (FDA) approval and the publication of OS evidence to understand better the risks and benefits of delaying approval until OS evidence is available.
Original Research
Glioblastoma (GB) treatment remains challenging because of recurrence and poorly defined treatment options after first-line therapy. To better understand real-world application of treatment paradigms and their impact on outcomes, the authors describe patterns of GB treatment, outcomes, and use of cancer-related healthcare resource in the USA.